Sucampo Pharmaceuticals Overview

Life ScienceCompany

Where is Sucampo Pharmaceuticals headquartered?

Sucampo Pharmaceuticals is headquartered in Bethesda, Maryland.

What is Sucampo Pharmaceuticals’ revenue?

Sucampo Pharmaceuticals disclosed revenue of 115M USD for 2014 and 89M USD for 2013.

How many employees does Sucampo Pharmaceuticals have?

Sucampo Pharmaceuticals has 80 employees.

What sector is Sucampo Pharmaceuticals in?

Sucampo Pharmaceuticals is a life science company.

When was Sucampo Pharmaceuticals founded?

Sucampo Pharmaceuticals was founded in 1996.

Sucampo Pharmaceuticals, Inc.

4520 East West Highway, 3rd Floor,
Bethesda, Maryland 20814
United States,
(301) 961-3400
www.sucampo.com

Sucampo Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of highly specialized medicines. Sucampo has a late-stage pipeline of product candidates in clinical development for orphan disease areas, including VTS-270, a mixture of 2-hydroxypropyl-B-cyclodextrins with a specific compositional fingerprint that has been granted orphan designation in the U.S. and Europe and is in a pivotal Phase 2/3 clinical trial for the treatment of Niemann-Pick Disease Type C, a rare progressive genetic disorder. VTS-270 has also been granted breakthrough therapy designation in the U.S. Sucampo has an exclusive option for the North American rights to CPP-1X/sulindac, which is in Phase 3 development for the treatment of familial adenomatous polyposis and has been granted orphan drug designation in the U.S. The company has two marketed products – AMITIZA and RESCULA.


M&A Summary

Buy vs Sell

Year ≤ '20 '21 '22 '23 '24 '25 T
Buy (0.0/yr) # 2 - - - - - 2
vol $475M $475M
Sell (0.0/yr) # - - - - - - 0
  2

Top M&A Advisors

Financial Deals
Jefferies
1
Moelis & Co.
1
Legal Deals
Cooley
2
Mori Hamada & Matsumoto
1

Try Mergr Free — See This and 220,573+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.